XML 25 R6.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2017     11,167,425        
Beginning balance at Dec. 31, 2017 $ 209,197 $ (171) $ 112 $ 47,079 $ 162,006 $ (171) $ 0
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]              
Issuance of stock in connection with the acquisition of Capella Education Company (in shares)     10,263,775        
Issuance of stock in connection with the acquisition of Capella Education Company 1,236,961   $ 103 1,236,858      
Filing fee related to new stock issuance (148)     (148)      
Stock-based compensation 14,994     14,994      
Exercise of stock options, net (in shares)     156,424        
Exercise of stock options, net 8,648   $ 1 8,647      
Issuance of restricted stock, net (in shares)     155,874        
Issuance of restricted stock, net (776)   $ 1 (777)      
Common stock dividends (27,842)       (27,842)    
Foreign currency translation adjustments 0            
Unrealized gains on marketable securities, net of tax 32           32
Net income (loss) (15,671)       (15,671)    
Ending balance (in shares) at Dec. 31, 2018     21,743,498        
Ending balance at Dec. 31, 2018 1,425,224   $ 217 1,306,653 118,322   32
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]              
Stock-based compensation 12,116     12,033 83    
Exercise of stock options, net (in shares)     103,364        
Exercise of stock options, net (1,773)   $ 2 (1,775)      
Issuance of restricted stock, net (in shares)     117,947        
Issuance of restricted stock, net (7,472)   $ 1 (7,473)      
Common stock dividends (46,724)       (46,724)    
Foreign currency translation adjustments 0            
Unrealized gains on marketable securities, net of tax 201           201
Net income (loss) 81,138       81,138    
Ending balance (in shares) at Dec. 31, 2019     21,964,809        
Ending balance at Dec. 31, 2019 $ 1,462,710 $ (3,311) $ 220 1,309,438 152,819 $ (3,311) 233
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]              
Accounting standards update us-gaap:AccountingStandardsUpdate201613Member            
Issuance of common stock in public offering (in shares)     2,185,000        
Issuance of common stock in public offering $ 220,248   $ 22 220,226      
Stock-based compensation 14,610     14,593 17    
Exercise of stock options, net (in shares)     20,522        
Exercise of stock options, net 1,244     1,244      
Issuance of restricted stock, net (in shares)     250,377        
Issuance of restricted stock, net (25,845)   $ 2 (25,847)      
Repurchase of common stock (in shares)     (1,769)        
Repurchase of common stock (247)     (105) (142)    
Common stock dividends (56,005)       (56,005)    
Foreign currency translation adjustments 48,068           48,068
Unrealized gains on marketable securities, net of tax 579           579
Net income (loss) 86,268       86,268    
Ending balance (in shares) at Dec. 31, 2020     24,418,939        
Ending balance at Dec. 31, 2020 $ 1,748,319   $ 244 $ 1,519,549 $ 179,646   $ 48,880